Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

4.94
Delayed Data
As of 3:43pm ET
 +0.08 / +1.65%
Today’s Change
4.65
Today|||52-Week Range
11.19
-6.44%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close4.86
Today’s open4.98
Day’s range4.91 - 5.00
Volume8,958
Average volume (3 months)16,653
Market cap$77.4M
Dividend yield--
Data as of 3:43pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+10.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book36.70

Competitors

 Today’s
change
Today’s
% change
TTNPTitan Pharmaceutical...+0.05+1.39%
SPHSSophiris Bio Inc+0.02+0.77%
BLRXBioLine RX Ltd-0.08-6.20%
FLKSFlex Pharma Inc+0.01+0.23%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateFebruary 24, 2017
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Vice President-Finance &
Accounting
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts


Search for Jobs